NEOPHARM INC·4

Feb 11, 3:20 PM ET

Birch Laurence 4

4 · NEOPHARM INC · Filed Feb 11, 2009

Insider Transaction Report

Form 4
Period: 2009-02-09
Birch Laurence
DirectorPresident, CEO and CFO
Transactions
  • Award

    Option to Buy

    2009-02-09+150,000150,000 total
    Exercise: $0.07Exp: 2019-02-09Common (150,000 underlying)
Footnotes (1)
  • [F1]Options vest and become exercisable in four equal installments of 37,500 options each on the first four anniversaries of the date of grant.

Documents

1 file
  • 4
    a4.xmlPrimary

    4